Biblio Discovery — Demo Discovery Service

11 results for "Alba Llibre"

Showing 1–11 · 0.95 seconds · RSS

  1. Journal Article

    Lessons from cross-pathogen studies: understanding the metabolic rewiring of macrophages upon infection

    Marisol Perez-Toledo; Alba Llibre

    Frontiers in Cellular and Infection Microbiology, Vol. 15 · 2025 · English · DOAJ Scopus

    Bacterial infections remain a significant cause of morbidity and mortality globally. Compounding the issue is the rise of antimicrobial-resistant strains, which limit treatment options. Macrophages play key roles in the immunity and pathogenicity of intracellular infections, such as those caused by…

  2. Journal Article

    Lactate: A key regulator of the immune response

    Alba Llibre; Salih Kucuk; Atrayee Gope et al.

    Immunity · 2025 · English · OpenAlex Scopus

    Lactate, the end product of both anaerobic and aerobic glycolysis in proliferating and growing cells-with the latter process known as the Warburg effect-is historically considered a mere waste product of cell and tissue metabolism. However, research over the past ten years has unveiled multifaceted…

  3. Journal Article

    Plasma Type I IFN Protein Concentrations in Human Tuberculosis

    Alba Llibre; Nicole Bilek; Vincent Bondet et al.

    Frontiers in Cellular and Infection Microbiology, Vol. 9 · 2019 · English · DOAJ Scopus

    Tuberculosis (TB) remains one of the leading causes of mortality worldwide, and a lack of understanding of basic disease pathogenesis is hampering development of new vaccines and treatments. Multiple studies have previously established a role for type I interferon (IFN) in TB disease. Type I IFNs…

  4. Journal Article

    Expression of lectin-like transcript-1 in human tissues [version 1; referees: 1 approved, 2 approved with reservations]

    Alba Llibre; Lucy Garner; Amy Partridge et al.

    F1000Research, Vol. 5 · 2016 · English · DOAJ Scopus

    Background: Receptor-ligand pairs of C-type lectin-like proteins have been shown to play an important role in cross talk between lymphocytes, as well as in immune responses within concrete tissues and structures, such as the skin or the germinal centres. The CD161-Lectin-like Transcript 1 (LLT1)…

  5. Journal Article

    Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities

    Alba Llibre; Martin Dedicoat; Julie G. Burel et al.

    Frontiers in Immunology, Vol. 12 · 2021 · English · DOAJ Scopus

    Mycobacterial diseases are a major public health challenge. Their causative agents include, in order of impact, members of the Mycobacterium tuberculosis complex (causing tuberculosis), Mycobacterium leprae (causing leprosy), and non-tuberculous mycobacterial pathogens including Mycobacterium…

  6. Journal Article

    Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment

    Priyanka Devi-Marulkar; Carolina Moraes-Cabe; Pascal Campagne et al.

    Frontiers in Immunology, Vol. 12 · 2021 · English · DOAJ Scopus

    BackgroundInterferon beta (IFNβ) has been prescribed as a first-line disease-modifying therapy for relapsing-remitting multiple sclerosis (RRMS) for nearly three decades. However, there is still a lack of treatment response markers that correlate with the clinical outcome of patients.AimTo…

  7. Journal Article

    Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

    Alba Llibre; Nikaïa Smith; Vincent Rouilly et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    Tuberculosis (TB) remains a major public health problem and we lack a comprehensive understanding of how Mycobacterium tuberculosis (M. tb) infection impacts host immune responses. We compared the induced immune response to TB antigen, BCG and IL-1β stimulation between latently M. tb infected…

  8. Journal Article

    Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis

    Loïs Bolko; Céline Anquetil; Alba Llibre et al.

    Frontiers in Immunology, Vol. 16 · 2025 · English · DOAJ Scopus

    ObjectiveThe objective of this study was to evaluate the presence of different types of interferon in idiopathic inflammatory myopathies (IIM) and their subgroups using ultrasensitive cytokine detection techniques (SIMOA) and to assess their potential as activity biomarkers.MethodsDisease activity…

  9. Journal Article

    Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis

    Nassima Bekaddour; Nikaïa Smith; Benoit Beitz et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    IntroductionAmong immune cells, activated monocytes play a detrimental role in chronic and viral-induced inflammatory pathologies, particularly in Juvenile Idiopathic Arthritis (JIA), a childhood rheumatoid arthritis (RA) disease. The uncontrolled activation of monocytes and excessive production of…

  10. Journal Article

    Machine Learning-Based Single Cell and Integrative Analysis Reveals That Baseline mDC Predisposition Correlates With Hepatitis B Vaccine Antibody Response

    Brian D. Aevermann; Casey P. Shannon; Mark Novotny et al.

    Frontiers in Immunology, Vol. 12 · 2021 · English · DOAJ Scopus

    Vaccination to prevent infectious disease is one of the most successful public health interventions ever developed. And yet, variability in individual vaccine effectiveness suggests that a better mechanistic understanding of vaccine-induced immune responses could improve vaccine design and…

  11. Journal Article

    Systems Biology Methods Applied to Blood and Tissue for a Comprehensive Analysis of Immune Response to Hepatitis B Vaccine in Adults

    Rym Ben-Othman; Bing Cai; Aaron C. Liu et al.

    Frontiers in Immunology, Vol. 11 · 2020 · English · DOAJ Scopus

    Conventional vaccine design has been based on trial-and-error approaches, which have been generally successful. However, there have been some major failures in vaccine development and we still do not have highly effective licensed vaccines for tuberculosis, HIV, respiratory syncytial virus, and…